Cardialysis is a leading specialist clinical research organization (CRO) with an exclusive focus on cardiology, providing a full range of clinical research and cardiovascular core laboratory services. Founded in 1983, Cardialysis is recognized for its opinion-leader expertise, strong academic network and in-depth cardiology expertise and in recent years has significantly expanded its operational activities. The world’s top medical device, biotechnology and pharmaceutical companies collaborate with Cardialysis resulting in more than 250 clinical trials conducted up till now, contributing to improved cardiovascular therapies.


Monitoring Services


Cardialysis continues to expand its monitoring network within Europe. Our Clinical Research Associates have at least 5 years of experience, are well-trained, ensure activation of your sites, the highest quality review of data and effective interaction with study sites. With over 1,600 sites monitored and more than 60,000 patients included Cardialysis has established a strong cardiology track record.

Structural Heart Core Lab

Structural Heart Core Lab_aangepast.png-1

Cardialysis structural heart core lab provides the perfect partner in conducting TAVI/TAVR or prosthetic valves clinical trials. Over the past few years thousands of imaging data from patients enrolled in several registries and clinical trials were successfully analysed and adjudicated by the core lab. These data are used for both CE mark and FDA submissions. 

Blog: Bioresorbable scaffolds


The first clinical studies testing the bioresorbable coronary scaffold in a small number of patients have shown very promising results with good clinical outcome up to 5 years' follow-up, highlighting important morphological and functional modifications at the scaffolded segment level, such as late lumen enlargement and recuperation of a normal vasoreactivity.